Pharmaceutical companies increase investment in real-world evidence generation to support post-market drug approvals
Pharmaceutical firms are significantly increasing investment in real-world evidence generation to support post-market drug approvals.
The story
in brief.
What happened, who it affects, and why it landed on our intelligence desk — in plain English, sixty seconds or less.
Pharmaceutical firms are significantly increasing investment in real-world evidence generation to support post-market drug approvals. Consequently, clinical research associates now face evolving requirements to collect and analyse real-world data. Professionals possessing expertise in epidemiology and data science are increasingly sought after by employers. This industry shift redirects career trajectories towards hybrid roles that combine traditional clinical knowledge with advanced statistical analysis capabilities, fundamentally altering skill demands within the sector.
Indicative index of skill mentions in professional job postings for the field this story moves (2019 = 1)
What this means
for your career.
Every headline redistributes opportunity. Here is who this one rewards — and how to be on the right side of it.
Your career trajectory must adapt to this data-driven shift. Clinical expertise alone is no longer sufficient; you need robust analytical skills. Epidemiology and data science are now premium assets. If you work in pharma, upskill immediately in statistical analysis and real-world data handling. Learn to bridge clinical insights with quantitative evidence. This hybrid skill set makes you indispensable for post-market surveillance roles. Do not wait for formal mandates. Proactively develop competencies in data interpretation and epidemiological methods. Your next career move should target roles that value both clinical understanding and technical proficiency. This strategic pivot ensures long-term relevance in an increasingly evidence-based industry landscape.
For this story, the fields that convert it into pay are Data Science, Epidemiology, Healthcare and AI in Pharmaceuticals — exactly the programmes matched below. The chart shows the indicative salary uplift certified professionals report in each of those fields; every one of them is a click away, from £79, finishing in as few as 20 days.
Indicative ranges from published continuing-education salary studies, by field — each field is a recommended course below
Enrol in these
to benefit.
These programmes position you for exactly this shift — online, self-paced, and finishing with a verifiable certificate you can share the day you pass.
Best match
Certificate in Data Science
Recommended
Certificate in Epidemiology
Recommended
Certificate in Healthcare
Recommended
Certificate in AI in Pharmaceuticals
Launch pricing shown against standard certificate value. The fee you see today is the fee you lock in.
Read the news. Then outrun it.
Every OnlineUni programme is online, self-paced and from £79 — so a headline today can be your credential this month.